Novel pancreatic beta cell-specific proteins: Antibody-based proteomics for identification of new biomarker candidates

Journal of Proteomics

Volumn 75, Issue 9, 2012, Pages 2611-2620

  Lindskog, Cecilia ^a   Korsgren, Olle ^a   Pontén, Fredrik ^a   Eriksson, Jan W ^b,c   Johansson, Lars ^c,d   Danielsson, Angelika ^a,d  

^a UPPSALA UNIVERSITY   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c ASTRAZENECA R AND D   (Sweden)

^d UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Antibody based proteomics; Beta cell biomarker; Diabetes; Immunohistochemistry; Islet biomarker

Indexed keywords

ANTIBODY; BIOLOGICAL MARKER; CELL PROTEIN; GLUCAGON; INSULIN;

ALGORITHM; ARTICLE; CONFOCAL MICROSCOPY; DIABETES MELLITUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS;

ANTIBODIES; BIOLOGICAL MARKERS; DATABASES, PROTEIN; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; GLUCAGON; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; IMMUNOHISTOCHEMISTRY; INSULIN; INSULIN-SECRETING CELLS; MEMBRANE GLYCOPROTEINS; MICROSCOPY, CONFOCAL; PROTEOMICS; RECEPTORS, IMMUNOLOGIC; RECEPTORS, PROSTAGLANDIN; SERPINS;

EID: 84860498528     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2012.03.008     Document Type: Article

References (40)

1. Sweet I.R., Cook D.L., Lernmark A., Greenbaum C.J., Krohn K.A. Non-invasive imaging of beta cell mass: a quantitative analysis. Diabetes Technol Ther 2004, 6:652-659.
2. Schneider S. Efforts to develop methods for in vivo evaluation of the native beta-cell mass. Diabetes Obes Metab 2008, 10(Suppl. 4):109-118.
3. Brom M., Andralojc K., Oyen W.J., Boerman O.C., Gotthardt M. Development of radiotracers for the determination of the beta-cell mass in vivo. Curr Pharm Des 2010, 16:1561-1567.
4. Goland R., Freeby M., Parsey R., Saisho Y., Kumar D., Simpson N., et al. 11C-Dihydrotetrabenazine PET of the pancreas in subjects with long-standing type 1 diabetes and in healthy controls. J Nucl Med 2009, 50:382-389.
5. Reiner T., Thurber G., Gaglia J., Vinegoni C., Liew C.W., Upadhyay R., et al. Accurate measurement of pancreatic islet {beta}-cell mass using a second-generation fluorescent exendin-4 analog. Proc Natl Acad Sci U S A 2011, 108:12815-12820.
6. Korner M., Stockli M., Waser B., Reubi J.C. GLP-1 receptor expression in human tumors and human normal tissues: potential for in vivo targeting. J Nucl Med 2007, 48:736-743.
7. Uhlen M., Ponten F. Antibody-based proteomics for human tissue profiling. Mol Cell Proteomics 2005, 4:384-393.
8. Uhlen M., Bjorling E., Agaton C., Szigyarto C.A., Amini B., Andersen E., et al. A human protein atlas for normal and cancer tissues based on antibody proteomics. Mol Cell Proteomics 2005, 4:1920-1932.
9. Nilsson P., Paavilainen L., Larsson K., Odling J., Sundberg M., Andersson A.C., et al. Towards a human proteome atlas: high-throughput generation of mono-specific antibodies for tissue profiling. Proteomics 2005, 5:4327-4337.
10. Uhlen M., Oksvold P., Fagerberg L., Lundberg E., Jonasson K., Forsberg M., et al. Towards a knowledge-based Human Protein Atlas. Nat Biotechnol 2010, 28:1248-1250.
11. Bjorling E., Lindskog C., Oksvold P., Linne J., Kampf C., Hober S., et al. A web-based tool for in silico biomarker discovery based on tissue-specific protein profiles in normal and cancer tissues. Mol Cell Proteomics 2008, 7:825-844.
12. Lindskog C., Asplund A., Engkvist M., Uhlen M., Korsgren O., Ponten F. Antibody-based proteomics for discovery and exploration of proteins expressed in pancreatic islets. Discov Med 2010, 9:565-578.
13. Goto M., Eich T.M., Felldin M., Foss A., Kallen R., Salmela K., et al. Refinement of the automated method for human islet isolation and presentation of a closed system for in vitro islet culture. Transplantation 2004, 78:1367-1375.
14. Friberg A.S., Stahle M., Brandhorst H., Korsgren O., Brandhorst D. Human islet separation utilizing a closed automated purification system. Cell Transplant 2008, 17:1305-1313.
15. Kononen J., Bubendorf L., Kallioniemi A., Barlund M., Schraml P., Leighton S., et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998, 4:844-847.
16. Kampf C., Andersson A., Wester K., Björling E., Uhlén M., Pontén F. Antibody-based tissue profiling as a tool for clinical proteomics. Clin Proteomics 2004, 1:285-299.
17. Warford A., Howat W., McCafferty J. Expression profiling by high-throughput immunohistochemistry. J Immunol Methods 2004, 290:81-92.
18. Paavilainen L., Wernerus H., Nilsson P., Uhlen M., Hober S., Wester K., et al. Evaluation of monospecific antibodies: a comparison study with commercial analogs using immunohistochemistry on tissue microarrays. Appl Immunohistochem Mol Morphol 2008, 16:493-502.
19. Taylor C., Wadey R., O'Donnell H., Roberts C., Mattei M.G., Kimber W.L., et al. Cloning and mapping of murine Dgcr2 and its homology to the Sez-12 seizure-related protein. Mamm Genome 1997, 8:371-375.
20. McDonald-McGinn D.M., Sullivan K.E. Chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Medicine (Baltimore) 2011, 90:1-18.
21. Claude A., Zhao B.P., Kuziemsky C.E., Dahan S., Berger S.J., Yan J.P., et al. GBF1: a novel Golgi-associated BFA-resistant guanine nucleotide exchange factor that displays specificity for ADP-ribosylation factor 5. J Cell Biol 1999, 146:71-84.
22. Niu T.K., Pfeifer A.C., Lippincott-Schwartz J., Jackson C.L. Dynamics of GBF1, a Brefeldin A-sensitive Arf1 exchange factor at the Golgi. Mol Biol Cell 2005, 16:1213-1222.
23. Marchese A., Sawzdargo M., Nguyen T., Cheng R., Heng H.H., Nowak T., et al. Discovery of three novel orphan G-protein-coupled receptors. Genomics 1999, 56:12-21.
24. Nagata K., Hirai H. The second PGD(2) receptor CRTH2: structure, properties, and functions in leukocytes. Prostaglandins Leukot Essent Fatty Acids 2003, 69:169-177.
25. Law R.H., Zhang Q., McGowan S., Buckle A.M., Silverman G.A., Wong W., et al. An overview of the serpin superfamily. Genome Biol 2006, 7:216.
26. Riewald M., Chuang T., Neubauer A., Riess H., Schleef R.R. Expression of bomapin, a novel human serpin, in normal/malignant hematopoiesis and in the monocytic cell lines THP-1 and AML-193. Blood 1998, 91:1256-1262.
27. Lobner K., Steinbrenner H., Roberts G.A., Ling Z., Huang G.C., Piquer S., et al. Different regulated expression of the tyrosine phosphatase-like proteins IA-2 and phogrin by glucose and insulin in pancreatic islets: relationship to development of insulin secretory responses in early life. Diabetes 2002, 51:2982-2988.
28. Saeki K., Zhu M., Kubosaki A., Xie J., Lan M.S., Notkins A.L. Targeted disruption of the protein tyrosine phosphatase-like molecule IA-2 results in alterations in glucose tolerance tests and insulin secretion. Diabetes 2002, 51:1842-1850.
29. Mbikay M., Seidah N.G., Chretien M. Neuroendocrine secretory protein 7B2: structure, expression and functions. Biochem J 2001, 357:329-342.
30. Azzoni C., Yu J.Y., Baggi M.T., D'Adda T., Timson C., Polak J.M., et al. Studies on co-localization of 7B2 and pancreatic hormones in normal and tumoural islet cells. Virchows Arch A Pathol Anat Histopathol 1992, 421:457-466.
31. Schmidt G., Sirois F., Anini Y., Kauri L.M., Gyamera-Acheampong C., Fleck E., et al. Differences of pancreatic expression of 7B2 between C57BL/6J and C3H/HeJ mice and genetic polymorphisms at its locus (Sgne1). Diabetes 2006, 55:452-459.
32. Bouatia-Naji N., Vatin V., Lecoeur C., Heude B., Proenca C., Veslot J., et al. Secretory granule neuroendocrine protein 1 (SGNE1) genetic variation and glucose intolerance in severe childhood and adult obesity. BMC Med Genet 2007, 8:44.
33. + channels: tuning beta-cell excitability with syntaxin-1A and other exocytotic proteins. Endocr Rev 2007, 28:653-663.
34. Vikman J., Svensson H., Huang Y.C., Kang Y., Andersson S.A., Gaisano H.Y., et al. Truncation of SNAP-25 reduces the stimulatory action of cAMP on rapid exocytosis in insulin-secreting cells. Am J Physiol Endocrinol Metab 2009, 297:E452-E461.
35. Villafuerte B.C., Barati M.T., Song Y., Moore J.P., Epstein P.N., Portillo J. Transgenic expression of insulin-response element binding protein-1 in beta-cells reproduces type 2 diabetes. Endocrinology 2009, 150:2611-2617.
36. Bustin M. Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins. Mol Cell Biol 1999, 19:5237-5246.
37. Reeves R., Beckerbauer L. HMGI/Y proteins: flexible regulators of transcription and chromatin structure. Biochim Biophys Acta 2001, 1519:13-29.
38. Fukusumi S., Fujii R., Hinuma S. Recent advances in mammalian RFamide peptides: the discovery and functional analyses of PrRP, RFRPs and QRFP. Peptides 2006, 27:1073-1086.
39. Chartrel N., Dujardin C., Anouar Y., Leprince J., Decker A., Clerens S., et al. Identification of 26RFa, a hypothalamic neuropeptide of the RFamide peptide family with orexigenic activity. Proc Natl Acad Sci U S A 2003, 100:15247-15252.
40. Egido E.M., Hernandez R., Leprince J., Chartrel N., Vaudry H., Marco J., et al. 26RFa, a novel orexigenic neuropeptide, inhibits insulin secretion in the rat pancreas. Peptides 2007, 28:725-730.